Walgreens Boots Alliance (WBA) shares are being converted into a cash payment of $ 11.45 $ 1 1 . 4 5 per share following the company's acquisition by Sycamore Partners, which closed in late August 2025. The stock has been delisted from the Nasdaq, meaning you no longer own equity in the company.
Walgreens stock will cease trading, and shareholders will receive $11.45 per share plus an additional up to $3 per share from the net proceeds of any potential future sales of VillageMD, the company said.
After the closing and the Nasdaq delisting, WBA common stock ceased to be exchange‑traded. That means you cannot buy or sell WBA common shares on Nasdaq or an equivalent public venue. Your former share ownership was converted into cash and the DAP Right.
Involuntary Delisting
In this case, promoters are required to buy back the shares at the value determined by an independent evaluator. Though delisting does not affect your ownership, shares may not hold any value post-delisting. Thus, if any of the stocks that you own get delisted, it is better to sell your shares.
Deal terms and valuation.
Shareholders received $11.45 per share in cash, totaling about $9.9 billion based on Walgreens' 865 million outstanding shares. They may also receive up to an additional $3 per share from the monetization of Walgreens' stake in VillageMD, bringing the total deal value up to $23.7 billion. 2.
To that end, Walgreens has agreed to be bought by Sycamore Partners. The deal is expected to close in the second half of 2025, with Walgreens shareholders getting $11.45 per share in cash. That's all that investors here can expect to receive if they buy Walgreens.
Trading Ends: Shares of WBA stock will be delisted after trading closes on August 27, 2025. No Future Ownership: Once private, investors will no longer own stock or have a say in Walgreens' direction.
If you own a delisted stock or ETF within your self-directed investing account, you have the following options: Continue holding the shares in your account with the hope that the security eventually gets re-listed. Sell your shares by submitting a limit order for the security that has been delisted.
In addition to their cash consideration of $11.45 per WBA share, WBA shareholders will receive one non-transferable right to receive up to an additional $3.00 in cash per WBA share from the net proceeds of the future monetization of WBA's debt and equity interests in VillageMD, which includes the Village Medical, ...
You have the right to accept or reject the offer—as long as you know what the consequences are. Most people don't own enough shares to viably reject an offer, and therefore, won't have a big effect on how the company's management will react. In the end, you may even be forced to sell your shares.
Sycamore Partners completed its acquisition of Walgreens (WBA) on August 28, 2025. Shareholders of WBA received $11.45 in cash for each share held at the close of trading on August 27, 2025. In addition, each shareholder was granted one non-transferable contingent value right (CVR) per share.
Analysts have given Walgreens (WBA) a Sell based on their latest research and market trends.
Experts from across the healthcare industry agree that while Walgreens is currently in a grim financial situation, recovery is still possible. To make this happen, the company will have to relinquish its retail clinic dreams and focus more on making its core pharmacy business as efficient as it can.
If you miss the chance to sell during the delisting process, you can sell your shares to the promoter for at least one year after delisting at the same price. If you still don't sell, you can try selling your shares on the over-the-counter (OTC) market.
In cases of voluntary delisting, SEBI requires the company to offer an exit window to public shareholders. This allows investors to sell their shares back to the promoters at a price determined through the Reverse Book Building process.
In case of Involuntary Delisting, your ownership of the shares is not affected, however, the value of your shares might get devalued after delisting. Thus, traders or investors generally sell their shares when the company announces buyback.
Investors holding shares after a delisting will only be able to sell them OTC. That generally means less liquidity, finding it harder to locate buyers at the price you want, and potentially being left in the dark about what the company is up to.
If you own securities, including stocks, and they become totally worthless, you have a capital loss but not a deduction for bad debt. Worthless securities also include securities that you abandon.
Walgreens Boots Alliance (WBA) aims to stabilize and grow its business in a challenging retail environment by focusing on cost management and operational efficiency. The company has publicly stated targets, including achieving $1 billion in cost savings and reducing capital expenditures by $600 million for fiscal 2024.
The Walgreens Boots Alliance Inc stock price today is 11.980.
As had been previously announced on March 6, under the terms of the Merger Agreement, WBA shareholders will receive $11.45 per share in cash at closing – approximately 8% above it value at the original time of the offer – and one non-transferable divested asset proceeds right to receive up to an additional $3.00 in ...